NDC 70573-099-01 - Ryplazim

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 70573-099
Requested NDC: 70573-099-01
Package NDCs from labels: 70573-099-01, 70573-099-02
Manufacturer: Kedrion Biopharma, Inc. | Prometic Bioproduction Inc. | Kedrion S.p.A.
Effective date: 2026-09-21
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
SUCROSE - Kedrion Biopharma, Inc. \| Prometic Bioproduction Inc. \| Kedrion S.p.A.	Kedrion Biopharma, Inc. \| Prometic Bioproduction Inc. \| Kedrion S.p.A.	2026-09-21	PLASMA DERIVATIVE

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
70573-099-01	Ryplazim	1 in 1 VIAL, GLASS	INJECTION, POWDER, LYOPHILIZED,	1		8
70573-099-02	Ryplazim	1 in 1 CARTON	INJECTION, POWDER, LYOPHILIZED,	1		8

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
70573-099	RYPLAZIM (PLASMINOGEN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [KEDRION BIOPHARMA, INC.]	7	Current NDC, Legacy NDC, 2 package rows	20250406_5c5a00ca-d662-46e6-b9ac-a07e9cfcc0a8.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
70573-099-01	EA - Each	70573-099	e46db168-3dcf-4de3-af8f-d484cb9740ba	1	2022-01-06
70573-099-02	EA - Each	70573-099	7499b387-849a-4c2d-b559-ce8646ddc5d9	1	2021-12-08

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 45 of 45 · 884 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Join
SODIUM CHLORIDE	SODIUM CHLORIDE	Baxter Healthcare Corporation	b3b4b176-41f0-4ca8-90d4-3fba5707564a	2014-02-21	Exact identifier unii: 451W47IQ8X
TIS-U-SOL	SODIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM SULFATE, SODIUM PHOSPHATE, AND POTASSIUM PHOSPHATE	Baxter Healthcare Corporation	9da4121f-d62d-4da4-8dfb-0494da16015f	2014-02-21	Exact identifier unii: 451W47IQ8X
Ringers	SODIUM CHLORIDE, CALCIUM CHLORIDE, POTASSIUM CHLORIDE,	Baxter Healthcare Corporation	e1953d54-818d-46a6-8532-518ebae6d84e	2012-06-13	Exact identifier unii: 451W47IQ8X
Lactated Ringers	SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE	Baxter Healthcare Corporation	f09f80bf-2f8b-4420-865d-aec2d5e5cd4d	2012-06-12	Exact identifier unii: 451W47IQ8X

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.